A
ABBV
ABBVIE INC.
$281.75
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of ABBVIE INC. in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$12.60
Yield
4.47%
EPS
$3.56
P/E
73.3
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $3.82
Oct 30
Posts
No posts about ABBV yet.
About ABBVIE INC.
AbbVie is a large US drugmaker that develops and sells prescription medicines. Its biggest earners are Skyrizi and Rinvoq, which treat immune conditions like psoriasis and Crohn's disease, plus Botox and other cosmetic treatments, and cancer and brain-health drugs. It earns money by selling these drugs to pharmacies, hospitals, and clinics, and it also pays shareholders a high dividend.